Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00507208 · ClinicalTrials.gov registry record · NA
Dynasplint Therapy for Trismus in Head and Neck Cancer
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT00507208 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 53 participants.
The verdict
NCT00507208, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the use of the Dynasplint Trismus System to routine trismus treatment in improving the ability of opening the mouth in a randomized trial. This study will also determine what effects, good and/or bad, this procedure has on the participant. Participants will be randomly assigned to the Dynasplint Trismus System or to routine treatment with tongue depressors.
Interventions
- DEVICE Dynasplint Trismus System
- OTHER Tongue Depressors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2007-07 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00507208
The ClinicalTrials.gov registry entry for NCT00507208 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dynasplint Trismus System is the first listed.
NCT00507208 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00507208 about?
NCT00507208 is a clinical study titled "Dynasplint Therapy for Trismus in Head and Neck Cancer". The purpose of this study is to compare the use of the Dynasplint Trismus System to routine trismus treatment in improving the ability of opening the mouth in a randomized trial. This study will also determine what effects, good and/or bad, this procedure has on the participant. Participants will be...
What is the current status of trial NCT00507208?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2007-07. Estimated completion is 2015-07.
What interventions are being tested in trial NCT00507208?
The interventions under investigation include: Dynasplint Trismus System (DEVICE), Tongue Depressors (OTHER).
Who is sponsoring clinical trial NCT00507208?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.